204 related articles for article (PubMed ID: 12917766)
1. Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma.
Lee KT; Liu TS
World J Surg; 2003 Oct; 27(10):1143-8. PubMed ID: 12917766
[TBL] [Abstract][Full Text] [Related]
2. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas.
Lee KT; Liu TS
Dig Dis Sci; 2001 Oct; 46(10):2166-72. PubMed ID: 11680592
[TBL] [Abstract][Full Text] [Related]
3. Expression of DPC4/Smad4 gene in stone-containing intrahepatic bile duct.
Lee KT; Chang WT; Wang SN; Chuang SC; Chai CY; Hu SW
J Surg Oncol; 2006 Sep; 94(4):338-43. PubMed ID: 16917866
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
5. Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.
Shimizu T; Yokomuro S; Mizuguchi Y; Kawahigashi Y; Arima Y; Taniai N; Mamada Y; Yoshida H; Akimaru K; Tajiri T
World J Gastroenterol; 2006 Oct; 12(39):6316-24. PubMed ID: 17072955
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.
Benckert C; Jonas S; Cramer T; Von Marschall Z; Schäfer G; Peters M; Wagner K; Radke C; Wiedenmann B; Neuhaus P; Höcker M; Rosewicz S
Cancer Res; 2003 Mar; 63(5):1083-92. PubMed ID: 12615726
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
Kang Y; Prentice MA; Mariano JM; Davarya S; Linnoila RI; Moody TW; Wakefield LM; Jakowlew SB
Exp Lung Res; 2000 Dec; 26(8):685-707. PubMed ID: 11195465
[TBL] [Abstract][Full Text] [Related]
8. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis.
Terada T; Nakanuma Y; Sirica AE
Hum Pathol; 1998 Feb; 29(2):175-80. PubMed ID: 9490278
[TBL] [Abstract][Full Text] [Related]
10. Lectin histochemical study of cholangiocarcinoma arising from stone-bearing intrahepatic bile duct.
Lee KT; Sheen PC
J Surg Oncol; 1995 Jun; 59(2):131-5. PubMed ID: 7776654
[TBL] [Abstract][Full Text] [Related]
11. [Expression of Smad4 and transforming growth factor-beta1, transforming growth factor-beta receptor II in cholangiocarcinoma tissue and its biological significance].
Zhang BY; Zhang JY; Zhao K; Wu LQ
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):846-9. PubMed ID: 16083599
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen expression in peribiliary glands of stone-containing intrahepatic bile ducts.
Lee KT; Sheen PC
Dig Dis Sci; 1999 Nov; 44(11):2251-6. PubMed ID: 10573370
[TBL] [Abstract][Full Text] [Related]
14. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
[TBL] [Abstract][Full Text] [Related]
15. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
16. Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model.
Manzanares MÁ; Usui A; Campbell DJ; Dumur CI; Maldonado GT; Fausther M; Dranoff JA; Sirica AE
Am J Pathol; 2017 May; 187(5):1068-1092. PubMed ID: 28315313
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
[TBL] [Abstract][Full Text] [Related]
18. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
Mariano JM; Montuenga LM; Prentice MA; Cuttitta F; Jakowlew SB
Int J Dev Biol; 1998 Nov; 42(8):1125-36. PubMed ID: 9879710
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor betas and their receptors in human liver cirrhosis.
Baer HU; Friess H; Abou-Shady M; Berberat P; Zimmermann A; Gold LI; Korc M; Büchler MW
Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1031-9. PubMed ID: 9895050
[TBL] [Abstract][Full Text] [Related]
20. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma.
Ohira S; Itatsu K; Sasaki M; Harada K; Sato Y; Zen Y; Ishikawa A; Oda K; Nagasaka T; Nimura Y; Nakanuma Y
Pathol Int; 2006 Jul; 56(7):381-9. PubMed ID: 16792547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
